Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Apeloa Jutai Pharmaceutical is a core subsidiary of Apeloa Pharmaceutical, a leading Chinese pharmaceutical company under the Hengdian Group. The company specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the fields of anti-infectives, cardiovascular health, and the central nervous system. Its manufacturing facilities are highly regarded, holding certifications from the US FDA, EU GMP, and Japan's PMDA, enabling it to serve a global market. Apeloa Jutai plays a vital role in the group's integrated CDMO strategy, providing high-quality chemical synthesis and manufacturing services to international pharmaceutical partners. The company is committed to technological innovation and maintains a robust portfolio of generic and proprietary drug products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江普洛巨泰药业.